|
1
|
Gharat SA, Momin M and Bhavsar C: Oral
squamous cell carcinoma: Current treatment strategies and
nanotechnology-based approaches for prevention and therapy. Crit
Rev Ther Drug Carrier Syst. 33:363–400. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Scully C and Bagan J: Oral squamous cell
carcinoma overview. Oral Oncol. 45:301–308. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li H, Fan H, Wang Z, Zheng J and Cao W:
Potentiation of scutellarin on human tongue carcinoma xenograft by
low-intensity ultrasound. PLoS One. 8:e594732013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hu Z, Lv G, Li Y, Li E, Li H, Zhou Q, Yang
B and Cao W: Enhancement of anti-tumor effects of 5-fluorouracil on
hepatocellular carcinoma by low-intensity ultrasound. J Exp Clin
Cancer Res. 35:712016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhou S, Yu T, Zhang J, Liu S, Huo Y and
Zhang Y: Sonochemotherapy inhibits the adhesion, migration and
invasion of human ovarian cancer cells with highly metastatic
potential. Ultraschall Med. 32 Suppl 1:S14–S20. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yu T, Li SL, Zhao JZ and Mason TJ:
Ultrasound: A chemotherapy sensitizer. Technol Cancer Res Treat.
5:51–60. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Trendowski M, Yu G, Wong V, Acquafondata
C, Christen T and Fondy TP: The real deal: Using cytochalasin B in
sonodynamic therapy to preferentially damage leukemia cells.
Anticancer Res. 34:2195–2202. 2014.PubMed/NCBI
|
|
8
|
Trendowski M: The promise of sonodynamic
therapy. Cancer Metastasis Rev. 33:143–160. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yu T, Yang Y, Zhang J, He H and Ren X:
Circumvention of cisplatin resistance in ovarian cancer by
combination of cyclosporin A and low-intensity ultrasound. Eur J
Pharm Biopharm. 91:103–110. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Z, Xu K, Bi Y, Yu G, Wang S, Qi X
and Zhong H: Low intensity ultrasound promotes the sensitivity of
rat brain glioma to Doxorubicin by down-regulating the expressions
of p-glucoprotein and multidrug resistance protein 1 in vitro and
in vivo. PLoS One. 8:e706852013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kotopoulis S, Delalande A, Popa M, Mamaeva
V, Dimcevski G, Gilja OH, Postema M, Gjertsen BT and McCormack E:
Sonoporation-enhanced chemotherapy significantly reduces primary
tumour burden in an orthotopic pancreatic cancer xenograft. Mol
Imaging Biol. 16:53–62. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu FT, Chen X, Wang J, Qin B and
Villanueva FS: Low intensity ultrasound mediated liposomal
doxorubicin delivery using polymer microbubbles. Mol Pharm.
13:55–64. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rizzitelli S, Giustetto P, Faletto D,
Delli Castelli D, Aime S and Terreno E: The release of Doxorubicin
from liposomes monitored by MRI and triggered by a combination of
US stimuli led to a complete tumor regression in a breast cancer
mouse model. J Control Release. 230:57–63. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lorusso D, Petrelli F, Coinu A,
Raspagliesi F and Barni S: A systematic review comparing cisplatin
and carboplatin plus paclitaxel-based chemotherapy for recurrent or
metastatic cervical cancer. Gynecol Oncol. 133:117–123. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Amable L: Cisplatin resistance and
opportunities for precision medicine. Pharmacol Res. 106:27–36.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dasari S and Tchounwou PB: Cisplatin in
cancer therapy: Molecular mechanisms of action. Eur J Pharmacol.
740:364–378. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stewart DJ: Mechanisms of resistance to
cisplatin and carboplatin. Crit Rev Oncol Hematol. 63:12–31. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Saad AH and Hahn GM: Ultrasound enhanced
drug toxicity of Chinese hamster ovary cells in vitro. Cancer Res.
49:5931–5934. 1989.PubMed/NCBI
|
|
19
|
Sausville EA and Burger AM: Contributions
of human tumor xenografts to anticancer drug development. Cancer
Res. 66:3351–3354. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bibby MC: Orthotopic models of cancer for
preclinical drug evaluation: Advantages and disadvantages. Eur J
Cancer. 40:852–857. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Teicher BA: Tumor models for efficacy
determination. Mol Cancer Ther. 5:2435–2443. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fan H, Jiang W, Li H, Fang M, Xu Y and
Zheng J: MMP-1/2 and TIMP-1/2 expression levels, and the levels of
collagenous and elastic fibers correlate with disease progression
in a hamster model of tongue cancer. Oncol Lett. 11:63–68. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zheng J, Xie L, Teng H, Liu S, Yoshimura
K, Kageyama I and Kobayashi K: Morphological changes in the lingual
papillae and their connective tissue cores on the
7,12-dimethylbenz[alpha]anthracene (DMBA) stimulated rat
experimental model. Okajimas Folia Anat Jpn. 85:129–137. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fujita K, Kaku T, Sasaki M and Onoé T:
Experimental production of lingual carcinomas in hamsters: Tumor
characteristics and site of formation. J Dent Res. 52:1176–1185.
1973. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zheng J, Wang Q, Li H, et al: Comparative
study on the tongue carcinoma model induced by local application
both of 7,12-dimethylbenz[a]anthracene (DMBA) and injury. Anatomy
Res. 29:405–409. 2007.
|
|
26
|
Lv Y, Zheng J, Zhou Q, Jia L, Wang C, Liu
N, Zhao H, Ji H, Li B and Cao W: Antiproliferative and
apoptosis-inducing effect of exo-protoporphyrin IX based
sonodynamic therapy on human oral squamous cell carcinoma. Sci Rep.
7:409672017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fan HX, Li HX, Chen D, Gao ZX and Zheng
JH: Changes in the expression of MMP2, MMP9, and ColIV in stromal
cells in oral squamous tongue cell carcinoma: Relationships and
prognostic implications. J Exp Clin Cancer Res. 31:902012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang Z, Chen J, Chen L, Yang X, Zhong H,
Qi X, Bi Y and Xu K: Low frequency and intensity ultrasound induces
apoptosis of brain glioma in rats mediated by caspase-3, Bcl-2, and
survivin. Brain Res. 1473:25–34. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang XY, Xun-Qu, Wang CQ, Liu GX, Zhou CJ
and Wang ZG: Expression of growth arrest and DNA damage inducible
45a in human oral squamous cell carcinoma is associated with tumor
progression and clinical outcome. J Cancer Res Ther. 10
Suppl:C108–C113. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li Y, Qian H, Li X, Wang H, Yu J, Liu Y,
Zhang X, Liang X, Fu M, Zhan Q and Lin C: Adenoviral-mediated gene
transfer of Gadd45a results in suppression by inducing apoptosis
and cell cycle arrest in pancreatic cancer cell. J Gene Med.
11:3–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pegg AE: Multifaceted roles of
alkyltransferase and related proteins in DNA repair, DNA damage,
resistance to chemotherapy, and research tools. Chem Res Toxicol.
24:618–639. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Christmann M, Verbeek B, Roos WP and Kaina
B: O(6)-Methylguanine-DNA methyltransferase (MGMT) in normal
tissues and tumors: Enzyme activity, promoter methylation and
immunohistochemistry. Biochim Biophys Acta. 1816:179–190.
2011.PubMed/NCBI
|
|
33
|
Chen SH, Kuo CC, Li CF, Cheung CH, Tsou
TC, Chiang HC, Yang YN, Chang SL, Lin LC, Pan HY, et al:
O6-methylguanine DNA methyltransferase repairs platinum-DNA adducts
following cisplatin treatment and predicts prognoses of
nasopharyngeal carcinoma. Int J Cancer. 137:1291–1305. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yu T, Xiong Z, Chen S and Tu G: The use of
models in ‘target theory to evaluate the survival curves of human
ovarian carcinoma cell line exposure to adriamycin combined with
ultrasound. Ultrason Sonochem. 12:345–348. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang L, Gao S, Jiang W, Luo C, Xu M,
Bohlin L, Rosendahl M and Huang W: Antioxidative dietary compounds
modulate gene expression associated with apoptosis, DNA repair,
inhibition of cell proliferation and migration. Int J Mol Sci.
15:16226–16245. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang J, Han X, Feng X, Wang Z and Zhang Y:
Coupling cellular localization and function of checkpoint kinase 1
(Chk1) in checkpoints and cell viability. J Biol Chem.
287:25501–25509. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang Y and Hunter T: Roles of Chk1 in
cell biology and cancer therapy. Int J Cancer. 134:1013–1023. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jackson SP and Helleday T: DNA REPAIR.
Drugging DNA repair. Science. 352:1178–1179. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang X, Simpson ER and Brown KA: p53:
Protection against tumor growth beyond effects on cell cycle and
apoptosis. Cancer Res. 75:5001–5007. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cheng SY, Seo J, Huang BT, Napolitano T
and Champeil E: Mitomycin C and decarbamoyl mitomycin C induce
p53-independent p21WAF1/CIP1 activation. Int J Oncol.
49:1815–1824. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Canne IG, Merrick KA, Morandell S, Zhu CQ,
Braun CJ, Grant RA, Cameron ER, Tsao MS, Hemann MT and Yaffe MB: A
pleiotropic RNA-binding protein controls distinct cell cycle
checkpoints to drive resistance of p53-defective tumors to
chemotherapy. Cancer Cell. 28:8312015. View Article : Google Scholar
|
|
42
|
Wang W, Zhang L, Wang Z, Yang F, Wang H,
Liang T, Wu F, Lan Q, Wang J and Zhao J: A three-gene signature for
prognosis in patients with MGMT promoter-methylated glioblastoma.
Oncotarget. 7:69991–69999. 2016.PubMed/NCBI
|
|
43
|
Hung CC, Chien CY, Chiang WF, Lin CS, Hour
TC, Chen HR, Wang LF, Ko JY, Chang CH and Chen JY: p22phox confers
resistance to cisplatin, by blocking its entry into the nucleus.
Oncotarget. 6:4110–4125. 2015. View Article : Google Scholar : PubMed/NCBI
|
